SMTL ID : 4cr5.1

Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

homo-dimer

Ligands

2 x 0TU: 6-chloroquinolin-2(1H)-one

0TU.1: 15 residues within 4Å: Chain A: D.182, A.183, C.184, K.185, S.188, T.206, S.207, W.208, G.209, G.211, C.212, G.219, V.220, Y.221 Ligands: SO4.3 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:A.183, A:T.206 Hydrogen bonds: A:K.185, A:G.209, A:G.211 0TU.9: 15 residues within 4Å: Chain B: D.182, A.183, C.184, K.185, S.188, T.206, S.207, W.208, G.209, G.211, C.212, G.219, V.220, Y.221 Ligands: SO4.11 5 PLIP interactions: 5 interactions with chain B Hydrophobic interactions: B:A.183, B:T.206 Hydrogen bonds: B:K.185, B:G.209, B:G.211

14 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 3 residues within 4Å: Chain A: H.82, Y.227, W.230 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:W.230 Salt bridges: A:H.82 SO4.3: 5 residues within 4Å: Chain A: H.44, K.185, G.186, S.188 Ligands: 0TU.1 7 PLIP interactions: 7 interactions with chain A Hydrogen bonds: A:G.186, A:D.187, A:S.188, A:S.188, A:S.188 Salt bridges: A:H.44, A:K.185 SO4.4: 6 residues within 4Å: Chain A: Y.134, L.137, R.138, D.139, K.185 Chain B: K.140 5 PLIP interactions: 4 interactions with chain A, 1 interactions with chain B Hydrogen bonds: A:Y.134, A:R.138, A:D.139 Salt bridges: A:K.185, B:K.140 SO4.5: 3 residues within 4Å: Chain A: T.5, A.6, Q.146 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:A.6, A:Q.146 SO4.6: 3 residues within 4Å: Chain A: E.11, K.195, W.200 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:W.200 Salt bridges: A:K.195 SO4.7: 2 residues within 4Å: Chain A: K.117, R.120 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:K.117, A:R.120 SO4.8: 4 residues within 4Å: Chain A: P.151, Y.176, R.177, E.178 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.177, A:E.178 SO4.10: 3 residues within 4Å: Chain B: H.82, Y.227, W.230 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:W.230 Salt bridges: B:H.82 SO4.11: 5 residues within 4Å: Chain B: H.44, K.185, G.186, S.188 Ligands: 0TU.9 7 PLIP interactions: 7 interactions with chain B Hydrogen bonds: B:G.186, B:D.187, B:S.188, B:S.188, B:S.188 Salt bridges: B:H.44, B:K.185 SO4.12: 6 residues within 4Å: Chain A: K.140 Chain B: Y.134, L.137, R.138, D.139, K.185 4 PLIP interactions: 3 interactions with chain B, 1 interactions with chain A Hydrogen bonds: B:R.138, B:D.139 Salt bridges: B:K.185, A:K.140 SO4.13: 3 residues within 4Å: Chain B: T.5, A.6, Q.146 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:A.6, B:Q.146 SO4.14: 3 residues within 4Å: Chain B: E.11, K.195, W.200 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:W.200 Water bridges: B:E.11 Salt bridges: B:K.195 SO4.15: 2 residues within 4Å: Chain B: K.117, R.120 2 PLIP interactions: 2 interactions with chain B Salt bridges: B:K.117, B:R.120 SO4.16: 4 residues within 4Å: Chain B: P.151, Y.176, R.177, E.178 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:R.177, B:E.178

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Fjellstrom, O. et al., Creating Novel Activated Factor Xi Inhibitors Through Fragment Based Lead Generation and Structure Aided Drug Design. Plos One (2015)

Release Date

2015-02-11

Peptides

COAGULATION FACTOR XIA: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

COAGULATION FACTOR XIA

Related Entries With Identical Sequence